Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?
1. KLTO stock surged 800% after positive pre-clinical results. 2. Research focuses on the s-KL protein for anti-aging treatments. 3. Company faces risks with no current revenue and significant cash burn. 4. Historical context shows most pre-clinical studies fail to progress. 5. Investor caution advised due to volatility and speculative nature.